The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
about
Lung cancer chemoprevention: current status and future prospectsMetformin and the risk of cancer: time-related biases in observational studiesReduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysisChemoprevention of lung cancer: prospects and disappointments in human clinical trialsAssociation between diabetes or antidiabetic therapy and lung cancer: A meta-analysisDoes chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort study.Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis.Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.Metformin and erlotinib synergize to inhibit basal breast cancer.Metformin use and lung cancer risk in patients with diabetes.Survival of patients with stage IV lung cancer with diabetes treated with metformin.Association of the metformin with the risk of lung cancer: a meta-analysis.Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.Cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator.Metformin use and young age lung cancer: A case series reportDiabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.Effect of Metformin on Different Non-Diabetes Related Conditions, a Special Focus on Malignant Conditions: Review of Literature.Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients.Histamine-2 receptor antagonists and risk of lung cancer in diabetic patients – an exploratory analysis.Metformin in lung cancer: rationale for a combination therapy.Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.Metformin, an old drug, brings a new era to cancer therapyDoes Metformin Reduce Cancer Risks? Methodologic Considerations.Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation.No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis.Comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129.Response to comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129.Re.: "Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis".One author replies.Re: "reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis".
P2860
Q26995495-F835F248-13C2-42E4-B21D-637B4223CF03Q26999266-EF9C1A84-C1F8-4617-869C-D179678EDF82Q27025309-904A35F8-2CCE-47AB-A604-D80B55045363Q28386632-29C4BFB8-7215-4FA3-A443-AAAD5F0BEA4DQ33607800-D2A40184-595E-496D-B27C-33E4B7E1C62AQ33650319-5CD17FDE-4AC4-4CA7-9E52-F77899200E39Q33748862-9499C24B-F1E4-4BFE-870F-1F5A4A8C0DF6Q34135248-6F780680-63AC-43DE-A327-034B8F91E517Q34786488-606B0B8B-66C3-453E-944F-597D580D6678Q35046673-432E6A4A-FF39-484A-86D5-42374EE8032CQ35153493-2AAE9867-388C-40C2-BBB4-BC9B5BF248EBQ35200421-DD3FB3B2-F1C2-4258-8FE1-EA98FB8ACE49Q35803926-7374E7F3-8959-41C6-A5A1-08697A06EBBBQ36024628-8AC04970-D51F-4E3F-B0AC-AFFDA1B0077FQ36741232-FA31AB6B-AA56-4418-A6B5-EA554F3E7DC7Q36794283-382E6D7D-3F48-4F89-A2A1-C744EADED42AQ37737183-3EC830A8-649C-4A11-BF3B-F3857D001163Q37742183-9C2C2BC0-166B-4121-AB7E-D4B203D86AF7Q38098148-4E9C7A48-2A6E-42F4-B053-15633657E2D9Q38128357-BF9C4FF8-5CCE-4D07-A66E-DBE2FA616F91Q38147841-23083108-3757-4AB2-B7B0-EC96B350FB5BQ38393435-7B25ED56-9667-4FAE-B68C-E51F411D44DDQ38687543-A3BE2078-CDD7-4153-B48E-0B20518B4BAEQ38999875-6CAABD25-F94F-442D-8091-DECD081AEC3DQ40778391-FA16939B-61A7-4A91-B204-3911552D0017Q41303279-4DF23C5C-4CCB-4B13-8B3A-19050686BC64Q43242157-5F20BAF2-CC0B-4328-9D4B-DCBAE41DFDACQ43242195-361D3600-2EA1-4547-826B-A23457852211Q43834371-05DB851C-F0F4-4FBA-911A-800F5CB37296Q44440589-630184DA-123A-4EAB-A69B-23E97DD81E4FQ51771567-4262E2C2-7511-4AFA-AC73-DE0AD11A350E
P2860
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
@ast
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
@en
type
label
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
@ast
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
@en
prefLabel
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
@ast
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
@en
P2093
P2860
P921
P356
P1433
P1476
The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
@en
P2093
Brielan B Smiechowski
Laurent Azoulay
Michael N Pollak
Samy Suissa
P2860
P304
P356
10.2337/DC12-0740
P407
P577
2012-08-24T00:00:00Z